Clincosm LogoSign in Get a demo

Carcinoma, Non-Small-Cell Lung

Showing NaN - NaN of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Worldwide (Nintedanib (BIBF1120), Pemetrexed, pemetrexed)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Nintedanib (BIBF1120)
  • +6 more
  • Downy, California
  • +166 more
Dec 8, 2016

NSCLC Trial in Worldwide (PF-02341066)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +278 more
Nov 17, 2016

NSCLC Trial in Worldwide (PF-02341066, Pemetrexed, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Little Rock, Arkansas
  • +263 more
Oct 31, 2016

NSCLC Trial in Taiwan, United States (BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • BIBW 2992
  • Bakersfield, California
  • +29 more
Jul 28, 2016

NSCLC Trial in Worldwide (MM-121, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +37 more
Jul 12, 2016

NSCLC Trial in Worldwide (, BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • placebo
  • BIBW 2992
  • Kingman, Arizona
  • +89 more
Jun 24, 2016

NSCLC Trial in Worldwide (Cisplatin, Gemcitabine, PF-3512676)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +120 more
Mar 10, 2015

NSCLC Trial in Worldwide (PF-3512676 + Paclitaxel + Carboplatin, Paclitaxel + Carboplatin)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • PF-3512676 + Paclitaxel + Carboplatin
  • Paclitaxel + Carboplatin
  • Little Rock, Alaska
  • +190 more
Mar 10, 2015

Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell Trial in Worldwide (CP-751,871 (Figitumumab),

Terminated
Has Results
  • Carcinoma, Squamous Cell
  • +3 more
  • CP-751,871 (Figitumumab)
  • +2 more
  • Florence, Alabama
  • +279 more
Dec 11, 2013

NSCLC Trial in Worldwide (Sorafenib + Paclitaxel + Carboplatin, Placebo + Paclitaxel + Carboplatin)

Terminated
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Sorafenib + Paclitaxel + Carboplatin
  • Placebo + Paclitaxel + Carboplatin
  • Guangzhou, Guangdong, China
  • +21 more
Dec 2, 2013

Gene Mutations in Non-Small Cell Lung Cancer Cells

Unknown status
  • Carcinoma, Non-Small-Cell Lung
    • Taipei, Taiwan
      National Taiwan University Hospital
    Nov 29, 2013

    NSCLC Trial in Taipei (Gefitinib, CT or MRI, Docetaxel)

    Terminated
    Has Results
    • Carcinoma, Non-Small-Cell Lung
    • Taipei, Taiwan
      Research Site
    Aug 1, 2013

    Carcinoma, Large Cell, NSCLC, Carcinoma, Squamous Cell Trial in Worldwide (CP 751,871 (Figitumumab), Erlotinib)

    Terminated
    Has Results
    • Carcinoma, Large Cell
    • +3 more
    • Fort Smith, Arkansas
    • +174 more
    Jul 22, 2013

    DNA Repair Genes and Outcomes in Patients With Stage III NSCLC

    Unknown status
    • Carcinoma, Non-Small-Cell Lung
    • Chemotherapy
      • Taipei, Taiwan
        National Taiwan University Hospital
      Jul 14, 2010

      NSCLC Trial in Taipei (Taxotere, Cisplatin, Gemcitabine)

      Unknown status
      • Carcinoma, Non-Small-Cell Lung
      • Taxotere, Cisplatin, Gemcitabine
      • Taipei, Ban-Ciao, Taiwan
        Chi-Huang Hsiao
      Feb 6, 2009

      Anorexia, Cachexia, Weight Loss Trial in Hong Kong, Taichung, Taipei (Betamarc)

      Terminated
      • Anorexia
      • +3 more
      • Hong Kong, China
      • +5 more
      Jul 19, 2008

      NSCLC Trial in Worldwide (LY900003)

      Completed
      • Carcinoma, Non-Small-Cell Lung
      • Hot Springs, Arkansas
      • +104 more
      Jul 18, 2006